Success Story: NIW Approval for a Molecular Biology Researcher Applying Advanced Proteomics to Human Disease Therapies
Client’s Testimonial:
“I am very satisfied with the professional and efficient service. The team was responsive, knowledgeable, and very helpful throughout the process. I truly appreciate their support and would highly recommend their services.”
On September 16th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Associate in the Field of Network Cell and Molecular Biology (Approval Notice).
General Field: Network Cell and Molecular Biology
Position at the Time of Case Filing: Postdoctoral Associate
Country of Origin: China
State of Residence at the Time of Filing: New York
Approval Notice Date: September 16th, 2026
Processing Time: 29 months, 18 days (Premium Processing Upgrade Requested)
Case Summary:
A robust record of independent research influence provided the foundation for this EB-2 National Interest Waiver (NIW) case. North America Immigration Law Group represented a specialist in network cell and molecular biology holding a D.Sc. in chemical biology.
An Established Record Before the Proposed Endeavor
Long before filing, the client's research had already attracted widespread attention and reliance from researchers across the global scientific community. The record documented 8 peer-reviewed journal articles and 2 granted patents, which together had accumulated 412 citations.
Rather than treating these citation figures as self-evidently sufficient, our team provided in-depth bibliometric analysis for the USCIS adjudicator to demonstrate the client's field-wide influence. The analysis established that 3 of his articles ranked among the top 10% most-cited publications for their respective publication years, while an additional 3 articles ranked in the top 20%. Furthermore, the client had demonstrated technical authority by completing at least 6 peer reviews for authoritative journals in chemical biology and pharmacology.
A Broader Proteomics Endeavor With Practical Applications
Against this background of demonstrated success, we presented the client’s proposed endeavor as a direct continuation of his specialized expertise. Currently conducting research at a major U.S. academic research institution, the client proposed to continue developing cutting-edge approaches to elucidate protein interactions and structures in various human diseases, including cancer.
The petition directly connected this proposed endeavor to pressing U.S. public health and economic priorities. Furthermore, the endeavor directly advances federally designated Critical and Emerging Technologies, specifically multi-omics, biometrology, and protein engineering.
Expert Support and NIW Approval
The petition was further corroborated by 4 recommendation letters from independent and collaborative field experts, who verified the technical necessity, original significance, and national value of the client's proteomics frameworks.
"This research is critical to the advancement of small-molecule drug production and exhibits the effect of [Client’s] research on organic chemistry, as well as the importance of his work on healthcare and pharmaceuticals in the United States."
By connecting the client's publication impact, top-tier bibliometric standings, patent output, peer-review service, and expert endorsements into a cohesive narrative, NAILG successfully secured the client's I-140 NIW approval. We congratulate the client on this achievement and look forward to his ongoing contributions to molecular biology, proteomics, and drug discovery in the United States.